Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Chernoff

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Nature Cell Biology|December 13, 2006
Regulation of protein tyrosine phosphatase 1B by sumoylationShrikrishna Dadke, Sophie Cotteret, Shu-Chin Yip, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 4, 2013
p21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shearJoseph E Aslan, Asako Itakura, Kristina M Haley, et al.
BMC Pharmacology & Toxicology|November 16, 2019
Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2)Yu-Chi Shen, Caroline Arellano-Garcia, Rosa E Menjivar, et al.
The Journal of Biological Chemistry|August 21, 2013
FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated SchwannomasSilvia Licciulli, Jasna Maksimoska, Chun Zhou, et al.
Elife|May 21, 2014
Pak2 is required for actin cytoskeleton remodeling, TCR signaling, and normal thymocyte development and maturationHyewon Phee, Byron B Au-Yeung, Olga Pryshchep, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Unique vulnerability of <i>RAC1</i>-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Oncogene|January 19, 2024
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Breast Cancer Research and Treatment|June 30, 2019
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancerVladislav Korobeynikov, Michelle Borakove, Yayi Feng, et al.
Oncotarget|October 15, 2016
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibitionOlga Villamar Cruz, Tatiana Y Prudnikova, Daniela Araiza-Olivera, et al.
Nucleic Acids Research|September 22, 2023
The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregationYilin Wang, Patrik Risteski, Yang Yang, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Nature Cell Biology|December 13, 2006
Regulation of protein tyrosine phosphatase 1B by sumoylationShrikrishna Dadke, Sophie Cotteret, Shu-Chin Yip, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 4, 2013
p21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shearJoseph E Aslan, Asako Itakura, Kristina M Haley, et al.
BMC Pharmacology & Toxicology|November 16, 2019
Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2)Yu-Chi Shen, Caroline Arellano-Garcia, Rosa E Menjivar, et al.
The Journal of Biological Chemistry|August 21, 2013
FRAX597, a small molecule inhibitor of the p21-activated kinases, inhibits tumorigenesis of neurofibromatosis type 2 (NF2)-associated SchwannomasSilvia Licciulli, Jasna Maksimoska, Chun Zhou, et al.
Elife|May 21, 2014
Pak2 is required for actin cytoskeleton remodeling, TCR signaling, and normal thymocyte development and maturationHyewon Phee, Byron B Au-Yeung, Olga Pryshchep, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Unique vulnerability of <i>RAC1</i>-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Oncogene|January 19, 2024
Unique vulnerability of RAC1-mutant melanoma to combined inhibition of CDK9 and immune checkpointsAlexa C Cannon, Konstantin Budagyan, Cristina Uribe-Alvarez, et al.
Breast Cancer Research and Treatment|June 30, 2019
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancerVladislav Korobeynikov, Michelle Borakove, Yayi Feng, et al.
Oncotarget|October 15, 2016
Reduced PAK1 activity sensitizes FA/BRCA-proficient breast cancer cells to PARP inhibitionOlga Villamar Cruz, Tatiana Y Prudnikova, Daniela Araiza-Olivera, et al.
Nucleic Acids Research|September 22, 2023
The TRIM69-MST2 signaling axis regulates centrosome dynamics and chromosome segregationYilin Wang, Patrik Risteski, Yang Yang, et al.
Pageof 18